{"authoredOn":"2015-01-15","contained":[{"code":{"coding":[{"code":"76388-713-25","display":"Myleran 2mg tablet, film coated","system":"http://hl7.org/fhir/sid/ndc"}]},"id":"med0304","resourceType":"Medication"}],"dosageInstruction":[{"doseAndRate":[{"doseQuantity":{"code":"mg","system":"http://unitsofmeasure.org","unit":"mg","value":6},"type":{"coding":[{"code":"ordered","display":"Ordered","system":"http://terminology.hl7.org/CodeSystem/dose-rate-type"}]}}],"route":{"coding":[{"code":"26643006","display":"Oral route (qualifier value)","system":"http://snomed.info/sct"}]},"sequence":1,"text":"6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL","timing":{"repeat":{"frequency":1,"period":1,"periodUnit":"d"}}}],"id":"medrx0306","identifier":[{"system":"http://www.bmc.nl/portal/prescriptions","use":"official","value":"12345689"}],"intent":"order","medication":{"reference":{"display":"Myleran 2mg tablet","reference":"#med0304"}},"reason":[{"concept":{"coding":[{"code":"92818009","display":"Chronic myeloid Leukemia (disorder)","system":"http://snomed.info/sct"}]}}],"requester":{"display":"Patrick Pump","reference":"Practitioner/f007"},"resourceType":"MedicationRequest","status":"active","subject":{"display":"Donald Duck","reference":"Patient/pat1"},"text":{"div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"medrx0306\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest &quot;medrx0306&quot; </p></div><p><b>identifier</b>: id:\u00a012345689\u00a0(use:\u00a0OFFICIAL)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a name=\"med0304\"> </a><blockquote><p/><p><a name=\"med0304\"> </a></p><p><b>code</b>: Myleran 2mg tablet, film coated <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.1.0/CodeSystem-v3-ndc.html\">National drug codes</a>#76388-713-25)</span></p></blockquote></td></tr></table><p><b>subject</b>: <a href=\"patient-example-a.html\">Patient/pat1: Donald Duck</a> &quot;Donald DUCK&quot;</p><p><b>authoredOn</b>: 2015-01-15</p><p><b>requester</b>: <a href=\"practitioner-example-f007-sh.html\">Practitioner/f007: Patrick Pump</a> &quot;Simone HEPS&quot;</p><h3>Reasons</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Chronic myeloid Leukemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#92818009)</span></td></tr></table><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</p><p><b>timing</b>: Once per 1 days</p><p><b>route</b>: Oral route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>","status":"generated"}}